Detalles de la búsqueda
1.
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).
Cancers (Basel)
; 16(10)2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38791882
2.
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Ther Adv Med Oncol
; 15: 17588359231165978, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37063779
3.
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
Target Oncol
; 16(4): 529-536, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076798
Resultados
1 -
3
de 3
1
Próxima >
>>